PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
22-Jun-2021 ProBioGen and LAVA Therapeutics N.V. Sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific B3C newswire
22-Jun-2021 CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Next 10 Years Centogene NV
22-Jun-2021 Jardiance® (empagliflozin) approved in Europe for the treatment of heart failure with reduced ejection fraction Boehringer Ingelheim
22-Jun-2021 Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas AstraZeneca
22-Jun-2021 Defence Therapeutics Inc.: DEFENCE THERAPEUTICS ACCUTOX EXHIBITS POTENT ANTI-CANCER PROPERTIES Defence Therapeutics Inc.
22-Jun-2021 Kuros Biosciences announces publication of data on MagnetOs in eCM Journal linking MOA to enhanced predictable bone regeneration Kuros Biosciences AG
22-Jun-2021 Xlife Sciences AG: Collaboration with the University of Marburg Xlife Sciences AG
22-Jun-2021 Rapid Nutrition PLC: Admission to trading on the Euronext Growth Paris Rapid Nutrition PLC
21-Jun-2021 Drägerwerk AG & Co. KGaA: Dräger increases guidance for fiscal 2021 Drägerwerk AG & Co. KGaA
21-Jun-2021 Funding boost supports growing high-tech companies in the UK Sciad Newswire
21-Jun-2021 Biotage Launches New Automated Platform for Plasmid DNA Purification B3C newswire
21-Jun-2021 Coriolis Pharma Expands its ATMP Development Facilities B3C newswire
21-Jun-2021 Implandata’s Breakthrough EYEMATE-SC Biosensor for Remote Glaucoma Care is CE Marked B3C newswire
21-Jun-2021 Lonza (Switzerland) and Epithelix (Switzerland) are the Leading Players in the In Vitro Lung Model Market MarketsandMarkets
21-Jun-2021 Relief Announces the Results of the Annual General Meeting 2021 of RELIEF THERAPEUTICS Holding AG: All Proposals Approved by a Large Majority RELIEF THERAPEUTICS Holdings AG
18-Jun-2021 Clinerion adds aggregate patient metrics for the real-world data on Patient Network Explorer with the RWD RADAR service. Clinerion Ltd.
18-Jun-2021 SMi’s 2nd Annual Pharmaceutical Cleanroom Conference Presents must attend workshops SMi Group
18-Jun-2021 European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis Sanofi
18-Jun-2021 Clinical Microbiology Market New High Growth Revenue Sources - An Update Markets and Markets
18-Jun-2021 Novartis Cosentyx® (secukinumab) recommended by NICE for adults with non-radiographic axial spondyloarthritis (nr-axSpA) Novartis